News & Analysis on Clinical Trial Services & Contract Research And Development
Regulators have published results from a six-year international active pharmaceutical ingredient inspection programme that Johnson Matthey says benefits companies and authorities.
Following one of the worst flu seasons in years, several companies are working to develop a universal vaccine, with the first clinical trials in humans now underway.
Catalent plans to invest $5m to create a new drug development center of excellence focusing on preclinical to clinical phase IIb formulation, analytical, and manufacturing solutions.